News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) To Host Research And Development Overview With Financial Analysts On November 17, 2004



10/19/2005 5:12:11 PM

NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company is hosting a meeting for the investment community at 8 a.m. on Wednesday, November 17 to provide a comprehensive update on the company's research and development efforts. Bristol-Myers Squibb executives will provide a complete overview of near and long-term prospects in the company's pipeline, including developmental medicines for cancer, diabetes, hepatitis B, rheumatoid arthritis, cardiovascular disease and other therapeutic areas.

For more information on the meeting, please visit the company's Investor Relations web site at http://www.bms.com/ir. Investors are invited to listen to a live webcast of the presentation, which also can be accessed at http://www.bms.com/ir. In addition, a replay of the presentation will be available until December 15, 2004.

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

Bristol-Myers Squibb Company

CONTACT: Media: Brian Henry, Corporate Affairs, +1-609-252-3337,brian.henry@bms.com; or Investor: John Elicker, Investor Relations,+1-212-546-3775, john.elicker@bms.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES